A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response
Clinical trial NCT00565981 · COMPLETED
Trial details
- NCT number
- NCT00565981
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2008-02-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.